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A B S T R A C T   
Background: Chemicals of Emerging Concern (CECs) include a very wide group of chemicals that are suspected to 
be responsible for adverse effects on health, but for which very limited information is available. Chromato-
graphic techniques coupled with high-resolution mass spectrometry (HRMS) can be used for non-targeted 
screening and detection of CECs, by using comprehensive annotation databases. Establishing a database 
focused on the annotation of CECs in human samples will provide new insight into the distribution and extent of 
exposures to a wide range of CECs in humans. 
Objectives: This study describes an approach for the aggregation and curation of an annotation database 
(CECscreen) for the identification of CECs in human biological samples. 
Methods: The approach consists of three main parts. First, CECs compound lists from various sources were 
aggregated and duplications and inorganic compounds were removed. Subsequently, the list was curated by 
standardization of structures to create “MS-ready” and “QSAR-ready” SMILES, as well as calculation of exact 
masses (monoisotopic and adducts) and molecular formulas. The second step included the simulation of Phase I 
metabolites. The third and final step included the calculation of QSAR predictions related to physicochemical 
properties, environmental fate, toxicity and Absorption, Distribution, Metabolism, Excretion (ADME) processes 
and the retrieval of information from the US EPA CompTox Chemicals Dashboard. 
Results: All CECscreen database and property files are publicly available (DOI: https://doi.org/10.5281/zenodo. 
3956586). In total, 145,284 entries were aggregated from various CECs data sources. After elimination of du-
plicates and curation, the pipeline produced 70,397 unique “MS-ready” structures and 66,071 unique QSAR- 
ready structures, corresponding with 69,526 CAS numbers. Simulation of Phase I metabolites resulted in 
306,279 unique metabolites. QSAR predictions could be performed for 64,684 of the QSAR-ready structures, 
whereas information was retrieved from the CompTox Chemicals Dashboard for 59,739 CAS numbers out of 
69,526 inquiries. CECscreen is incorporated in the in silico fragmentation approach MetFrag. 
Discussion: The CECscreen database can be used to prioritize annotation of CECs measured in non-targeted 
HRMS, facilitating the large-scale detection of CECs in human samples for exposome research. Large-scale 
detection of CECs can be further improved by integrating the present database with resources that contain 
CECs (metabolites) and meta-data measurements, further expansion towards in silico and experimental (e.g., 
MassBank) generation of MS/MS spectra, and development of bioinformatics approaches capable of using cor-
relation patterns in the measured chemical features.  
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1. Introduction 
Environmental exposures are a key contributor to disease and pre-
mature death (Landrigan et al., 2018). Yet, only a fraction of chemicals 
produced in significant amounts with potential to enter the environment 
have sufficient information to characterize human exposure levels and 
toxicity. Furthermore, information on potential by-products as well as 
biotic and abiotic transformation products is almost unknown (Land-
rigan et al., 2018; Vermeulen et al., 2020). Chemicals for which limited 
information is available in terms of exposure and toxicity and chemicals 
for which we do not know the existence off are commonly referred to as 
“known unknowns” and “unknown unknowns” (Little et al., 2012), 
respectively. Characterizing these exposures are critical to identify the 
role of the chemical exposome in human health and to advance non- 
targeted analytical platforms for universal chemical surveillance 
screening (Vermeulen et al., 2020). Of particular interest are Chemicals 
of Emerging Concern (CECs) (Sauvé and Desrosiers, 2014). This label is 
used by various agencies around the world to classify chemicals of po-
tential concern to human or environmental health due to expected 
toxicity or exposure levels, but for which very limited information 
related to either quantity is available. Due to this broad classification, 
the number of CECs is extremely high and ever changing and includes 
compounds with a wide variety of chemical properties and uses (e.g. 
pesticides, flame retardants, surfactants, pharmaceuticals, etc). Ap-
proaches such as suspect screening and effect-directed analysis (EDA) 
try to shed light on the presence of CECs in human biological matrices 
and other complex samples. 
The goal of this work is to develop a universal screening database of 
CECs for exposome research (Pourchet et al., 2020; Vermeulen et al., 
2020), with emphasis on detection of CECs in biological samples 
collected from human populations. An example of the possible appli-
cation of this database in exposome research is included in Pourchet 
et al. (2021). Due to the large number of CECs, targeted assessment of 
exposure levels in human samples is too costly, time consuming and 
often requires large sample volumes (Wishart et al., 2018). Chroma-
tography techniques, including liquid chromatography (LC) or gas 
chromatography (GC), combined with high-resolution mass spectrom-
etry (HRMS) provides an opportunity to screen for the presence of a 
wide range of CECs in human samples. 
A major challenge in the use of HRMS to detect CECs in human 
samples is the assignment of chemical identities to the several thousands 
of mass spectral signals (“chemical features”) that are detected in a 
typical non-targeted HRMS analysis. While identification of these 
chemical features requires validation with authentic standards (i.e., 
comparison of retention times and MS/MS spectra), etc. (Schymanski 
et al., 2014), an initial annotation that provides potential chemical 
identities is possible by comparing the accurate mass from the detected 
chemical features to a database that contains exact masses of known 
compounds. Although this technique requires a priori information on 
compounds that might be present, this is a useful approach within 
exposome research to ‘zoom in’ on a specific compound class/group of 
compounds of interest and may facilitate the selection of relevant fea-
tures to focus on for identification. Further insight into the biological 
impact of the annotated compounds can be acquired by combining this 
approach with other tools such as the fully untargeted screening of the 
metabolome. However, many chemical features will remain unanno-
tated and subsequent steps are needed to identify “unknown unknowns” 
specifically. 
Although many databases exist, few are suitable for the annotation of 
CECs in biological samples. Metabolomics databases, such as HMDB, 
(Wishart et al., 2018; Wishart et al., 2007) the Kyoto Encyclopedia of 
Genes and Genomes (KEGG) (Kanehisa and Goto, 2000) and METLIN 
(Guijas et al., 2018), primarily incorporate compounds that have been 
reported in literature. Both HMDB and KEGG were primarily designed as 
a resource for compounds present in the human endogenous metab-
olome, while METLIN includes both endogenous metabolites and 
environmental chemicals, including >700 000 chemicals from the US 
EPA “Distributed Structure-Searchable Toxicity (DSSTox)” database. 
(Grulke et al., 2019) The U.S. Environmental Protection Agency has 
created the CompTox Chemicals Dashboard (Williams et al., 2017), 
which combines physicochemical properties, reference counts and a 
wide-range of additional meta-data for over 882,000 chemicals, 
providing one of most comprehensive chemical databases currently 
available for exposome research. The suspect lists created under the 
NORMAN network (https://www.norman-network.com/nds/SLE/) also 
provides a large source of potential CECs, however these lists are mostly 
focused on environmental monitoring. Additional databases include 
PubChem (Kim et al., 2019) and ChemSpider (Pence and Williams, 
2010), both of which contain information on millions of chemical 
structures; however, both PubChem and ChemSpider suffer from the 
potential for false-positive matches, due to chemical entries that have an 
extremely low probability of representing true environmental expo-
sures. While all of these databases provide critical resources for anno-
tation of non-targeted HRMS features, the large number of chemicals, 
focus on endogenous metabolites or chemicals found in environmental 
samples, and limited ability to define compounds as CECs limits appli-
cation for annotation of CECs in biological samples. 
Two other databases, the Blood Exposome Database (Barupal and 
Fiehn, 2019) and the Exposome Explorer (Neveu et al., 2017), focus 
specifically on compounds present in the exposome. The Exposome 
Explorer (now included in HMDB v4.0) contains a systematically 
collected and manually curated collection of 908 compounds that are 
reported in the literature as measured in human samples. The high- 
quality standards of the Exposome Explorer, due to manual curation, 
have resulted in the small scale. The Blood Exposome Database is larger 
(n = 65,957) and incorporates a text mining approach to include 
potentially relevant information from the literature. However, this 
database is tailor made to blood only, not other matrices such as urine 
and includes many endogenous compounds. 
Although a large number of data sources dealing with CECs exist we 
believe there is still need for a comprehensive annotation database for 
CECs focused on screening in human matrices specifically. In this work, 
performed in the frame of the Human Biomonitoring for Europe 
(HBM4EU) initiative (https://www.hbm4eu.eu/), CECscreen, a data-
base of CECs including their predicted Phase I metabolites that can be 
used as an annotation source in exposome research is introduced. This 
database is a compilation of existing data sources dealing with CECs 
considered to be important for screening in human samples and includes 
annotation databases from the environmental field and regulatory 
agencies among others. Furthermore, to ensure applicability for anno-
tation in HRMS data, curation and standardization of the retrieved CECs 
are performed in the form of “MS-ready” structures (McEachran et al., 
2018). The use of “MS-ready” structures help link the common substance 
form to the form detected by HRMS in annotation databases. As most 
CECs will undergo metabolism in the human body and are therefore 
likely more prominently present as metabolite(s) than as a parent 
compound, the inclusion of Phase I metabolites would also improve the 
applicability of this database as an annotation source in human samples. 
The database was populated by collating a large number of lists of CECs 
produced by (regulatory) agencies and academic initiatives around the 
world. We describe here the applied qualitative consolidation and 
harmonization approach, steps that were taken to make the database 
“MS-ready”, identification of relevant metadata, and generation of 
predicted metabolites. Further, it describes how the CECscreen com-
pares with existing annotation resources, such as Exposome Explorer 
and the Blood Exposome Database and provides perspective on future 
developments that will further improve the identification of CECs in 
human biological samples. 
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2. Methods 
2.1. Identification and compilation of CECs data sources 
A general overview of the steps included in the curation work of this 
database is provided in Fig. 1. As an initial screening, data sources 
containing CECs were identified in a questionnaire in 2017 by members 
of the HBM4EU initiative. Compound name, Chemicals Abstract Service 
(CAS) number, and Simplified Molecular-Input Line Entry Specification 
(SMILES, when available) were extracted from the individual databases. 
Databases were merged based on CAS number. Using the CAS number as 
input, the “webchem” package (Szöcs et al., 2020) in R was used to 
retrieve missing SMILES. Entries for which no SMILES could be retrieved 
were excluded from the list. 
2.2. Data curation and preparation for CECs screening 
Correctness of the SMILES was evaluated by checking whether the 
valency matches the structures. Subsequently, adjusted KNIME work-
flows of Mansouri et al. (2016) and McEachran et al. (2018) were used to 
generate “MS- (Mansouri et al., 2016) and QSAR-ready” structures 
(McEachran et al., 2018) (Figure SM-1). The first step of the workflow 
was the removal of inorganic compounds, which are defined here as all 
substances without the element carbon. Subsequently, organic mixtures 
were split and each mixture constituent was entered into CECscreen as a 
separated entry with a link to the other constituents. In addition, any 
resulting inorganic components related to salts, plus water were 
removed. The final step to create “MS-ready” structures was chemical 
transformation and neutralization of the compounds to the forms that 
could be found in HRMS. To create “QSAR-ready” structures, stereo-
chemistry information was removed from the “MS-ready” structures. A 
more detailed description of the standardization and transformation 
steps in the workflows was published by McEachran et al. (2018). The 
original workflows were adjusted by removing the organometallic filter 
and retaining the stereochemistry information for the “MS-ready” 
structures. Furthermore, log P values were predicted based on the “MS- 
ready” structures using the XLogP (Wang et al., 1997) node from the 
KNIME CDK plug-in (Beisken et al., 2013). 
OpenBabel (O’Boyle et al., 2011) was used to convert the “MS- and 
QSAR-ready” SMILES into canonical SMILES, InChIs and InChIKeys. The 
“doBy” package (Højsgaard and Halekoh, 2006) in R was used to sum-
marize the CECs list based on unique “MS-ready” InChIKeys and 
duplicates were removed. The first CAS number and compound name 
that was reported for the structures were put in a separate column to be 
used as main identifier. The other variants were reported in another 
column to avoid losing this information. Monoisotopic mass, masses of 
commonly occurring adducts, molecular formula and remaining charge 
were calculated using the RChemMass package (Schymanski, 2019) in 
R. The adducts included were [M+H]+, [M+Na]+, [M+NH4]+, [M− H]−
and [M+CH3COO]− . 
2.3. Simulation of metabolites 
The comprehensive and open source software tool BioTransformer 
was used for the prediction of metabolites (Djoumbou-Feunang et al., 
2019). CDK objects representing structures were generated using the 
“QSAR-ready” canonical SMILES and saved in an SDF file that was im-
ported in the BioTranformer software (Djoumbou-Feunang et al., 2019). 
Metabolites were predicted using the Phase I (CYP450) transformation 
option and the program was run in Windows via the command line. Data 
retrieved included metabolite ID, predicted Phase I metabolite InChI and 
InChIKey, biotransformation reaction, enzymes involved and precursor 
“QSAR-ready” InChIKeys. Further data curation was performed similar 
to the curation work of the aggregated CECs list. In addition, compound 
name and CAS numbers were retrieved based on the InChIKeys using the 
“webchem” package (Szöcs et al., 2020) in R. 
2.4. Generation of physicochemical properties, environmental fate, and 
toxicity endpoints 
2.4.1. CompTox Chemicals Dashboard 
The CompTox Chemicals Dashboard (Williams et al., 2017) was used 
to retrieve existing and predicted data on toxicity, exposure and prev-
alence in the literature of the entries in the aggregated list. Batch 
searches based on CAS numbers were performed containing 5000 
compounds per batch. Information extracted from the CompTox 
Chemicals Dashboard included predicted median exposure in mg/kg 
bodyweight /day, availability of Toxicity Value data, ToxCast data 
(number of assays and percentage active), number of PubMed articles, 
chemicals and products database count and TEST toxicity predictions 
including 48 h Daphnia magna exposure LC50, developmental toxicity, 
Ames mutagenicity, oral rat LD50, Tetrahymena pyriformis IGC50 and 
96 h fathead minnow LC50. 
Fig. 1. The three major steps and sub steps in the 
pipeline to create a “MS-ready” database of CECs for 
screening in human samples. The first step is the 
aggregation of existing CECs lists and standardization 
to produce structure forms that can be measured with 
MS or are compliant with QSAR models. In the sec-
ond step, metabolites are simulated and their struc-
tures are standardized. In the final step, metadata is 
collected and predicted for physicochemical proper-
ties, environmental fate, and toxicity.   
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2.4.2. OPERA 
The OPEn (q)saR App (OPERA) (Mansouri et al., 2018) was used for 
the prediction of physicochemical properties, environmental fate, 
toxicity endpoints and ADME properties. MDL molfiles (v2000) were 
created from the “QSAR-ready” smiles and saved in an SDF file and 
imported into the OPERA User Interface (UI). Physicochemical proper-
ties that were predicted included the octanol–water partitioning coef-
ficient (log P), melting point, boiling point at 760 mm Hg, vapor 
pressure, water solubility at 25 ◦C, Henry’s Law constant, octanol–air 
partitioning coefficient, HPLC retention time, logarithmic acid dissoci-
ation constant (pKa) and octanol–water distribution coefficient (log D). 
The environmental fate predictions included the fish bioconcentration 
factor (log BCF), OH rate constant for atmospheric gas-phase reactions, 
biodegradation half-life, ready biodegradability of organic chemicals, 
whole body primary biotransformation rate constant and soil adsorption 
coefficient of organic compounds. Toxicity endpoints predicted included 
acute toxicity, agonistic and antagonistic estrogen, as well as androgen 
receptor activity. Finally, the ADME endpoints that were predicted 
included the human plasma fraction unbound and the human hepatic 
intrinsic clearance. 
2.5. Software and hardware 
All data mining, curation and modelling was performed on a HP 
desktop computer with an Intel® Core™ i7-4790 CPU 3.60 GHz pro-
cessor and 16.0 GB RAM with a 64-bit Windows 10 operating system. 
Data handling and curation was performed using version 3.5.1 of the R 
Project for Statistical Computing software (Team R, 2013) with the 
“webchem” (Szöcs et al., 2020), “doBy” (Højsgaard and Halekoh, 2006), 
“RChemMass” (Schymanski, 2019), enviPat (Loos et al., 2015) and rcdk 
(Guha, 2007) packages installed. Rcdk was installed to access the 
functionalities of the JAVA Chemistry Development Kit (Steinbeck et al., 
2003). Furthermore, the KNIME Analytics Platform version 4.0.0 
(Berthold et al., 2009) was used with the Marvin Chemistry (ChemAxon. 
Marvin., 2014) and CDK extensions (Beisken et al., 2013) to run the pre- 
build “MS-ready” (Mansouri, 2017) and “QSAR-ready” (Mansouri, 
2017) workflows as well as OpenBabel version 2.4.1 (O’Boyle et al., 
2011). BioTransformer version 1.1.0 (Djoumbou-Feunang et al., 2019) 
was used to predict metabolites and the Open (q)saR App (OPERA) 
(Mansouri et al., 2018) was used for the prediction of several physico-
chemical properties, environmental fate, toxicity endpoints and Ab-
sorption, Distribution, Metabolism, Excretion (ADME) properties. 
3. Results 
3.1. Identification, aggregation and curation of CECscreen 
The questionnaire provided to HBM4EU members resulted in the 
identification of 11 databases of CECs (Table 1), as well as the CompTox 
Chemicals Dashboard, which included at that stage 40 CECs lists 
(Table SM-1), several of which were integrated via the NORMAN Suspect 
List Exchange (https://www.norman-network.com/nds/SLE/). In total 
145,284 entries were included in the databases, which contained 
107,655 unique CAS numbers and 109,237 unique SMILES. 
For 30,740 entries with missing structural information in the data-
bases, no SMILES structure could be retrieved with the “webchem” 
package (Szöcs et al., 2020) in R and these entries were therefore 
excluded (as described in the methods). Furthermore, another 3227 
inorganics were excluded. Multi-component entries were separated and 
the organic mixture constituents were reinserted, resulting in a total 
number of 116,758 entries in the compiled list. Removal of duplicates 
and standardization of structures resulted in a total of 70,397 unique 
“MS-ready” structures and 66,071 unique QSAR-ready structures, which 
corresponds to 29,504 unique chemical formulas (DOI: https://doi. 
org/10.5281/zenodo.3956586). The monoisotopic masses range based 
on the “MS-ready” structures was from 16 to 6981 Da (Fig. 2). 
CECscreen and related metabolites are also directly incorporated into 
MetFrag (Ruttkies et al., 2016) (https://msbi.ipb-halle.de/MetFrag/). 
3.2. Metabolite predictions: CECscreen_Metabolite_DB 
BioTransformer was able to predict Phase I metabolites for 51,094 
out of the 66,071 (77.3%) QSAR-ready structures, resulting in 434,953 
transformations. After duplicate removal and standardization of struc-
tures 306,279 unique metabolites remained. 205,765 products were 
formed by hydroxylation, 43,429 by epoxidation, 22,121 by deal-
kylation, 13,029 by oxidation, 12,039 by desaturation, 6878 by reduc-
tion. The remaining 3018 products were formed by other types of 
reaction like ring opening, deisopropylation, dearylation, desulfuriza-
tion, dehydrogenation, NS-cleavage, dechloroethylation, deboronation, 
dealkoxylation, depropargylation and formation of iminium or pyr-
idinium (Fig. 3). As many of these predicted compounds may or may not 
already be known in databases, the R package “webchem” (Szöcs et al., 
2020) was used to retrieve compound name and CAS numbers based on 
the InChIKeys, which resulted in the retrieval of 24,872 (8.1%) names 
and 8257 (2.7%) CAS numbers. For 8233 (2.7%) metabolites, both the 
name and CAS number were retrieved. 
3.3. CompTox Chemicals Dashboard results: CECscreen_Comptox_DB 
CompTox Chemicals Dashboard information was retrieved for 
56,445 out of the 69,526 CAS numbers reported in CECscreen (Table 2). 
5.895 (8.5%) of the matches included estimations of exposure and 
Table 1 
List names, compound count and list description of the CECs data sources pro-
posed by members of the HBM4EU project.  
List name Compound 
count 
List description 
NORMAN merged suspects 
list dated 24/05/2017 
14,633 Collection of NORMAN suspect 
lists for environmental monitoring 
(NORMAN, 2015; Network et al., 
2020) 
EFSA FoodToxDB 5812 Compilation of chemical and 
toxicological information on 
compounds assessed by EFSA ( 
EFSA, 2002) 
ECHA Candidate list 203 list of emerging chemicals of high 




25,267 European Commission list with 
information on cosmetic chemicals 
and ingredients (European 
Commission, 2017) 
REACH ANNEX III 64,900 List of substances likely to meet the 
criteria of Annex III of the REACH 
regulation (ECHA, 2017) 
List of PBT/vPvBsubstances 
(67/548/EECd and 793/ 
93/EECe) 
128 List of suspected PBT and vPvB 
chemicals under the previous EU 
chemicals legislation (ECHA, 2007) 
T3DB 3674 Database containing target 
information about toxins (TMIC, 
2014; Wishart et al., 2015) 
US EPA CPCAT database 
(includes SPIN 2000) 
43,600 Database containing chemical 
information and usage in consumer 
products (Epa, 2017) 
OECD HPV 2007 4645 OECD list of high production 
volume chemicals (IOMC, 2009) 
EC EDS list 433 European Commission List of 
possible endocrine disrupting 
chemicals (European Commission, 
2017) 
TEDX list 1409 List of potential endocrine 
disrupting compounds (TEDX, 
2017) 
US EPA Chemicals 
Dashboard lists 
74,705 Collection of CECs lists retrieved 
from the US EPA Chemistry 
Dashboard (Epa, 2017)  
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18,553 (26.7%) also contained information from the chemicals and 
products database. For 11,266 (16.2%) of the matches ToxVal data was 
available, while 6544 (9.4%) of the matches also included ToxCast data. 
Source links to the ToxVal data is also included in the curated database. 
TEST toxicity prediction could be retrieved for between 24,639 (35.4%) 
and 37,541 (54.0%) of the entries depending on the endpoint. 
Furthermore, for 15,190 (21.8%) to 39,812 (57.3%) entries predictions 
related to several chemical properties could be retrieved. Finally, 11,939 
(17.2%) of the matches included information on the number of times it is 
referenced in articles found on PubMed. 
Fig. 2. Histogram of the monoisotopic masses (A) and the predicted XLogP values (B) of the entries in the combined CECs list. Bin width is 1 Da and 0.1 for A and B, 
respectively. 
Fig. 3. Bar graph of different transformation reaction frequencies resulting 
from the BioTransformer predictions. Numbers above the bars represent the 
total percentage of metabolites predicted through that specific transformation 
reaction. “Other” includes ring opening, deisopropylation, dearylation, desul-
furization, dehydrogenation, NS-cleavage, dechloroethylation, deboronation, 
dealkoxylation, depropargylation and formation of iminium or pyridinium. 
Table 2 
Summary of the data retrieved from the CompTox Chemicals Dashboard batch 
search of 69,526 CAS numbers. Detailed information with regards to the 
extracted information from the CompTox Chemicals Dashboard can be retrieved 
from Williams et al. (United States Environmental Protection Agency (US EPA), 
2020).   
Count % of 
inquiry 
Min Max Median 




5895 8.48 2.96e− 09 2.81e− 4 1.67e− 07 
ToxVal availability 11,266 16.2 – – – 
ToxCast (% active) 6544 9.4 0 73.84 2.98 
PubMed articles 
(count) 
11,939 17.2 1 280,169 22 
CPDat (count) 18,553 26.7 1 522,354 4 
TEST predictions 
(Tox)      
BCF 32,431 46.6 1.92e− 05 529,633 14.4 
48hr Daphnia 
LC50 (M) 
33,607 48.3 1.75e− 13 0.19 3.17e− 05 
96hr Fathead 
minnow LC50 (M) 
32,562 46.8 5.12e− 12 0.89 2.97e− 05 
40hr T. pyriformis 
IGC50 (M) 
24,639 35.4 5.61e− 11 1.63 1.33e− 04 
Oral rat LD50 
(mol/kg) 
31,084 44.7 2.50e− 07 0.25 6.67e− 03 
DevTox 37,541 54.0 − 1.63 1.55 0.65 
AMES 
mutagenicity 
37,208 53.5 − 0.59 1.48 0.26 
TEST predictions (physical properties) 
Boiling point (◦C) 34,836 50.1 − 70.02 1018.6 308.49 
Density (g/cm3) 39,356 56.6 0.57 4.78 1.21 
Flash point (◦C) 38,021 54.7 − 47.26 1431.4 157.25 
Melting point (◦C) 39,812 57.3 − 140.83 904.32 89.28 
Surface tension 
(dyn/cm) 




18,571 26.7 24.15 275.91 141.85 
Viscosity 
(viscosity cP) 
19,890 28.6 0.13 986.28 6.40 
Vapor pressure 
(mmHg) 
35,041 50.4 6.15e− 27 27,605.8 3.09e− 05 
Water solubility 
(M) 
38,018 54.7 3.16e− 14 19.68 9.84e− 04  
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3.4. OPERA results: CECscreen_OPERA_Predictions 
OPERA predictions were executed on 64,684 QSAR-ready structures, 
excluding organometallic compounds and those with a mass >1000 Da 
(Table 3). Data retrieved included the predictions but also information 
on whether a compound is within the applicability domain (AD) of the 
QSAR model as well as confidence indices that represents the reliability 
of the prediction based on the the accuracy of prediction of the five most 
similar compounds (Mansouri et al., 2018). Predictions were performed 
for 96.3% to 100% of the structures depending on the endpoint with 
exception of pKa predictions, which were achieved for 42% for acidic 
pKa and 33.8% for basic pKa. The number of compounds within the AD 
varied notably between endpoints. For the physical chemical properties, 
the number of compounds within the AD ranged from 53.7% to 88.8%. 
Similar figures were found for predicted environmental fate endpoints 
with 48.5% to 85.5% of the compounds falling within the AD. A larger 
proportion of the compounds were included in the AD for the toxicity 
and ADME endpoints with numbers ranging from 97.5% to 100% and 
86.1% to 86.9%, respectively. The same pattern was also observed for 
the confidence indices, as the average confidence index of the toxicity 
endpoints is abundantly higher than for the other endpoints and with 
lower standard deviation. 
4. Discussion 
The aim of the present study was to establish a database of CECs 
(CECscreen) for screening of these compounds in human biological 
samples, using non-targeted HRMS and thus to provide a resource for 
chemical annotation of the exposome. The database includes not only 
the CECs themselves, but also their corresponding Phase I metabolites 
that are likely to be present in human samples. The database was 
established by aggregating and curating existing chemicals databases 
containing CECs selected via a survey and by taking necessary steps to 
make the database “MS-ready”. Furthermore Phase I metabolites for all 
parent compounds included in the database were simulated and infor-
mation related to physicochemical properties, environmental fate, and 
toxicity were retrieved and predicted. 
Combining and aggregating the CECs lists resulted in 70,397 unique 
“MS-ready” (i.e., desalted structures, with mixtures separated into 
components) and 66,071 unique “QSAR-ready” structures in CECscreen. 
Furthermore, primary metabolite simulation resulted in an additional 
306,279 compounds in CECscreen_Metabolite_DB, i.e. 376,676 com-
pounds all together. However, the chemical space that is classified as 
CECs changes over time due to our increasing understanding of CECs 
and their health effects. Therefore, this list should be periodically 
updated to incorporate new CECs. Many compounds in CECscreen were 
also included in the CompTox Chemicals Dashboard (CEC-
screen_CompTox_DB), but the amount of data available for the different 
endpoints varied widely. The diversity in data availability highlights the 
need for agnostic and systematic non-targeted approaches to gain more 
insight into CECs (Vermeulen et al., 2020). CECscreen also includes 
predictions of physicochemical properties, environmental fate and 
toxicity (CECscreen_OPERA_Predictions). In addition to the predicted 
properties, data was included whether the chemical falls within the AD 
of that particular QSAR model Predictions were performed for a major 
part of the list, although the portion of compounds falling within theAD 
of the QSARs varied between endpoints. 
There is a degree of uncertainty in all predictions and this informa-
tion is important for evaluation and to facilitate prioritization. There-
fore, information with regards to confidence of prediction is included in 
the metadata files of CECscreen where available. Measures of confidence 
of predicted values in the CompTox Chemicals Dashboard were not 
available. However, for EXPOCAST predictions, a hyperlink is provided 
in CECscreen that links to the CompTox Chemicals Dashboard page 
which includes 95% confidence intervals of the predicted exposure 
values. For OPERA predictions a confidence index is provided which is a 
measure of the reliability of prediction when the query chemical falls 
within the AD and is calculated based on the prediction accuracy of the 
five most similar compounds of the query chemical. A detailed 
description of the implementation of such an approach is reported in 
Sahigara et al. (2012). 
The current state of CECscreen and associated files function as a first 
step to facilitate screening for CECs in human populations. The overlap 
based on unique InChIKey between CECscreen and other exposome 
focused databases like the Human Blood Exposome Database, Exposome 
Explorer and DSSTox is illustrated in Fig. 4. The largest overlap of 
CECscreen is with the DSSTox database, which is also incorporated into 
METLIN (72.4%). However, this is still only a minor fraction of the total 
DSSTox database (6.4%) which also incorporates a large number of 
endogenous compounds and predicted metabolites. Furthermore, over 
half of the Exposome Explorer database is also included into CECscreen. 
The overlap of CECscreen with the Blood Exposome Database is rela-
tively small. A total of 13,175 compounds overlap between the data-
bases which accounts for 18.7% and 20.2% of CECscreen and the Blood 
Exposome Database, respectively. The difference between the databases 
is most likely the result of the large number of blood related endogenous 
markers that are included in the Blood Exposome Database, which are 
outside the scope of CECscreen and the different aggregation methods 
used. The limited overlap between the Blood Exposome Database and 
Table 3 
Results from the running of the OPERA QSAR models on the QSAR-ready smiles. 
Data shown include the number of predictions made and percentage of the 
complete list. Furthermore, data are shown about the number of compounds 
within the applicability domain (AD) of the QSAR model and the average con-
fidence index regarding the reliability of the prediction based on the accuracy of 
prediction of the five most similar compounds. Mansouri et al. provides a 
detailed description of all included prediction endpoints (Mansouri et al., 2018).   
Predictions Within AD Confidence 
Index 
Count % Count % Average SD 
Physicochemical properties 
Boiling point 64,641 99.9 34,708 53.7 0.53 0.19 
Henry’s Law constant 64,606 99.9 35,333 54.6 0.39 0.17 
KOA 64,681 100.0 35,974 55.6 0.62 0.22 
log P 64,593 99.9 56,614 87.5 0.58 0.13 
Melting point 64,641 99.9 57,527 88.9 0.56 0.15 
Vapor pressure 64,672 100 48,957 75.7 0.46 0.17 
Water solubility 64,578 99.8 56,401 87.2 0.53 0.14 
HPLC RT 64,565 99.8 53,813 83.2 0.52 0.07 
pKa a 27,151 42 52,537 81.2 0.57 0.15 
pKa b 21,883 33.8 52,537 81.2 0.57 0.15 
log D 64,493 99.7 50,117 77.5 0.57 0.11  
Environmental fate 
log BCF 64,571 99.8 51,196 79.2 0.54 0.10 
AOH 64,601 99.9 31,393 48.5 0.54 0.10 
BioDeg 62,320 96.4 10,433 16.1 0.55 0.13 
RBioDeg 62,304 96.3 55,498 85.8 0.60 0.16 
KM 64,583 99.8 46,691 72.2 0.51 0.12 
KOC 62,299 96.3 48,879 75.6 0.52 0.16  
Toxicological endpoints 
CERAPP-Binding 64,680 100 64,518 99.7 0.92 0.07 
CERAPP-Agonist 64,671 100 64,370 99.5 0.94 0.07 
CERAPP-Antagonist 64,680 100 64,334 99.5 0.93 0.07 
CoMPARA-Binding 64,594 99.9 64,593 99.9 0.93 0.07 
CoMPARA-Agonist 64,592 99.9 64,580 99.8 0.97 0.05 
CoMPARA- 
Antagonist 
64,594 99.9 64,517 99.7 0.93 0.07 
CATMoS-VT 64,680 100 64,657 100 0.96 0.04 
CATMoS-NT 64,671 100 64,669 100 0.91 0.04 
CATMoS-EPA 64,676 100 64,649 100 0.84 0.06 
CATMoS-GHS 64,607 99.9 64,605 99.9 0.85 0.08 
CATMoS-LD50 64,679 100 63,083 97.5 0.84 0.10  
ADME endpoints 
FuB 64,679 100 55,721 86.1 0.63 0.07 
Clint 64,678 100 56,233 86.9 0.44 0.15  
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CECscreen, which are both of approximately equal size, illustrates the 
added value of these aggregation approaches. 
A strength of CECscreen is the inclusion of “MS- and QSAR-ready” 
structures as well as the addition of simulated Phase I metabolites to 
ensure applicability for screening in human biological samples using 
non-targeted HRMS. Furthermore, monoisotopic mass and the exact 
masses of several common adduct species such as [M+H]+, [M+Na]+, 
[M+NH4]+, [M− H]− and [M+CH3COO]− are included for ease of use in 
several workflows. CECscreen also provides structural information as 
SMILES, which can be used to generate additional adduct species if 
required (Schymanski, 2019). Finally, the inclusion of metadata 
regarding physicochemical properties, environmental fate, and toxicity 
allows for prioritization of CECs of interests most appropriate for the 
research question, and/or to enhance the annotation confidence. For 
instance, selection could be based on the chemical properties that would 
make it active in humans according to Lipinski’s rule of five (Hann and 
Kesër, 2012) or the probability of toxicity. Furthermore, information 
such as log P or log D can be used in retention time prediction under 
certain conditions and can potentially increase the annotation confi-
dence (Aalizadeh et al., 2019). Metadata terms should be used with 
caution during prioritization, however, as the absence of toxicity in-
formation does not necessarily imply a lack of toxicity. Furthermore, due 
to the limitation of the models, there is no distinction between enan-
tiomers which might behave differently. 
Additional approaches that reduce data dimensionality using 
endpoint information can also be used for chemical prioritization, and to 
limit the number of features requiring annotation in a study. For 
instance, an EDA approach (Jonker et al., 2019; Zwart et al., 2020) can 
be used to extract only those features that are related to a measured 
biological effect of interest or by applying variable selection approaches 
to select features associated with a toxicological mechanism (Warth 
et al., 2017; Shen et al., 2014). Both of these techniques greatly reduce 
the total amount of features to be considered and therefore facilitate 
compound annotation. For an illustration of such an application of 
CECscreen in an annotation approach, see Figure SM-2. There are many 
other prioritization approaches available, e.g. signal intensity, charac-
teristic isotope pattern or selection based on functional groups (Hol-
lender et al., 2017). However, careful consideration should be given to 
the type of approach to be used to reach optimal efficiency. For instance, 
prioritization based on the highest peak intensities would not be optimal 
to screen for lower intensity CECs in a matrix with a high intensity of 
endogenous markers (Andra et al., 2017). 
CECscreen and CECscreen_Metabolite_DB are large: by aggregating 
all available information in various existing databases, the number of 
CECs is high and this number is further expanded due to the inclusion of 
simulated Phase I metabolites. As a result, the screening process will 
produce a large number of annotations including a high fraction of false 
positives. Compound identification requires comparison of multiple 
orthogonal properties, including retention time, accurate mass and MS/ 
MS spectra, to authentic standards analysed under the same analytical 
conditions (Schymanski et al., 2014). This process is costly and 
cumbersome and identification of all annotated compounds is not 
feasible. However, several approaches are available to improve the 
likelihood of correctly annotating features, which reduces the number of 
false positives and can aid in the selection of which annotated com-
pounds should be identified. The incorporation into MetFrag (see below) 
is one way of facilitating these steps. 
The use of tandem mass spectral information especially appears 
necessary to increase annotation confidence. Several tandem mass 
spectral libraries are available online, such as MassBank (Horai et al., 
2010) and METLIN (Guijas et al., 2018), which already contain MS/MS 
fragmentation information including different fragmentation conditions 
and collision modes for a large number of chemicals. In addition, several 
resources and initiatives have also started to aggregate MS/MS libraries 
for different systems and under different acquisition conditions, 
including the HBM4EU initiative, complementarity to the present work 
(Horai et al., 2010; Oberacher et al., 2020). Despite these repositories 
and efforts, collection of MS/MS spectra for chemicals for which no 
standards are available, for instance, CECs metabolites produced by the 
human body, remains difficult. In order to get more insight in these 
types of compounds, in silico generation of MS/MS spectra approaches 
have been suggested (Chao et al., 2020; Dührkop et al., 2020; Dührkop 
et al., 2019). The in silico fragmenter MetFrag can combine database 
searches and MS/MS fragmentation prediction together and in this re-
gard increase annotation confidence (Ruttkies et al., 2016). To facilitate 
this process, CECscreen is directly incorporated into MetFrag under the 
names of “HBM4EU_CECscreen_MF_Jul2020” and “HBM4EU_CEC-
screen_MF_Jul2020plusTPs” without and with Phase I metabolites, 
Fig. 4. Venn diagram of the overlapping unique InChIKeys between CECscreen, DSSTox, Exposome Explorer and Blood Exposome Database. These databases contain 
both CECs and endogenous metabolites. 
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respectively. 
Several further steps can be undertaken in an attempt to reduce the 
percentage of false positive annotations. Based on the features generated 
by LC-HRMS, these include the use of information on retention time 
characteristics, mass defect, and isotope/adduct patterns (Scheubert 
et al., 2013) to characterize modules of features with correlated in-
tensity levels found by hierarchical clustering (Uppal et al., 2017). If 
sufficient pathway level information is available, such clusters can be 
assessed for pathway level correlations to increase the annotations 
confidence for correlated features present in the same cluster. The 
approach has been described successfully with databases that contain 
pathways of endogenous metabolites such as KEGG (Uppal et al., 2017). 
Similar databases containing information on CECs metabolic pathways 
would need to be developed to apply this approach on a large scale. 
The effective application of this database in screening human bio-
logical samples for CECs is dependent on the compartment that is 
measured. Phase I metabolites might be detected more frequently in 
blood samples whereas the metabolites detected in urine are often the 
result of Phase II metabolism. The BioTransformer software used to 
simulate the Phase I metabolites also includes a module to create Phase 
II metabolites, which can be easily applied to the “QSAR-ready” struc-
tures included in the CECscreen (Djoumbou-Feunang et al., 2019), 
however, considering the possibility that multiple Phase II metabolites 
are simulated from the Phase I metabolites, this will enlarge the volume 
of the database dramatically and could slow down the annotation pro-
cedure significantly. Furthermore, there are uncertainties in the validity 
of the metabolites as these were the product of simulation and not 
measurement. For example, multiple metabolites were simulated for the 
same compound but no information was provided on the likeliness of 
occurrence. As a result, some predicted metabolites may be detected 
more frequently, whilst others might not occur at all. Therefore, when 
available, CAS numbers and compound names were retrieved for the 
simulated metabolites in order to provide users a means to perform 
literature searches to determine if an annotated match is feasible. 
However, subsequent steps are still necessary to confirm the annotated 
metabolite (e.g. in vitro metabolism studies (Jia and Liu, 2007), MS/MS 
mass shifts (Boix et al., 2016)). 
BioTransformer covers a wide range of chemical substrates including 
xenobiotics and different metabolic biotransformation reactions. 
Therefore, the simulated Phase I metabolites is considered to be an 
appropriate first step to facilitate CECs metabolite identification in 
exposome research (Djoumbou-Feunang et al., 2019). Initiatives are in 
progress that measure and document existing metabolites of a wide 
range of CECs such as the activities within the US EPA, NORMAN-SLE 
and PubChem (US EPA, 2004; LCSB-ECI, 2020). These measured me-
tabolites should in time also be included in CECscreen. The presence of 
predicted metabolites in annotation databases such as CECscreen will 
help finding new metabolites in samples, which in turn will add to the 
knowledge on existing metabolites. 
The approach described here resulted in the first version of the 
CECscreen database tailored for annotation of CECs in human samples 
and offers users metadata to prioritize compounds based on their own 
research question. Most of the generated metadata was the result of 
prediction models and simulations. As the understanding of CECs in-
creases over time, actual measured values should be added to the da-
tabases. The addition of information on compound class, usage and 
production volumes would also be a valuable contribution to the data-
base for prioritization and application (Fischer, 2017). Furthermore, 
including adduct species information that are specific for certain LC- 
HRMS methods is valuable as well, although can cause file size infla-
tion. All information required to produce these species are included in 
the database. The current list is mainly focused on LC-HRMS types of 
data acquisitions, but can be extended for GC-HRMS. The chemical 
space investigated with GC–MS can also be important in the scope of 
studying the exposome, especially to investigate the link between vol-
atile parent compounds and their metabolites with health effects. 
4.1. Hosting 
CECscreen, CECscreen_Metabolite_DB, CECscreen_CompTox_DB and 
CECscreen_OPERA_Predictions are hosted by the NORMAN Suspect List 
Exchange (NORMAN, 2015) and also available on Zenodo (Meijer et al., 
2020) via DOI: https://doi.org/10.5281/zenodo.3956586. The database 
is also included in the CompTox Chemicals Dashboard (Williams et al., 
2017)(https://comptox.epa.gov/dashboard/chemical_lists/ 
CECSCREEN), PubChem via the NORMAN-SLE Classification Browser 
(https://pubchem.ncbi.nlm.nih.gov/classification/#hid=101) and is 
incorporated in MetFrag (https://msbi.ipb-halle.de/MetFrag/) (Rutt-
kies et al., 2016). 
CRediT authorship contribution statement 
Jeroen Meijer: Conceptualization, Methodology, Formal analysis, 
Investigation, Data curation, Writing - original draft, Visualization, 
Writing - review & editing. Marja Lamoree: Conceptualization, Writing 
- review & editing. Timo Hamers: Conceptualization, Writing - review 
& editing. Jean-Philippe Antignac: Conceptualization, Writing - re-
view & editing, Supervision, Project administration. Sébastien Hutinet: 
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package to retrieve chemical information from the web. J. Stat. Softw. https://doi. 
org/10.18637/jss.v093.i13. 
Team R., 2013. The R Project for Statistical Computing. https://doi.org/10.1159/ 
000323281. 
TEDX. Search the TEDX List. https://endocrinedisruption.org/interactive-tools/tedx-list- 
of-potential-endocrine-disruptors/about-the-tedx-list (accessed October 23, 2017). 
TMIC, 2017. The Toxin and Toxin Target Database (T3DB). http://www.t3db.ca/. 
Published 2014 (accessed October 23, 2017). 
Trier, X., Lunderberg, D., 2015. S9|PFASTRIER|PFAS Suspect List: fluorinated 
substances. November 2015. https://doi.org/10.5281/zenodo.3542121. 
United States Environmental Protection Agency (US EPA). US EPA CompTox Chemistry 
Dashboard. https://comptox.epa.gov/dashboard (accessed May 5, 2020). 
Uppal, K., Walker, D.I., Jones, D.P., 2017. xMSannotator: an R package for network- 
based annotation of high-resolution metabolomics data. Anal. Chem. 89 (2), 
1063–1067. https://doi.org/10.1021/acs.analchem.6b01214. 
US EPA. Biotransformation and ToxCast. https://cfpub.epa.gov/si/si_public_record_repor 
t.cfm?Lab=NCCT&TIMSType=&count=10000&dirEntryId=211445&search 
All=&showCriteria=2&simpleSearch=0&startIndex=20001. Published 2004. 
(accessed May 1, 2020). 
Vermeulen, R., Schymanski, E.L., Barabási, A.L., Miller, G.W., 2020. The exposome and 
health: Where chemistry meets biology. Science (80-) 367 (6476), 392–396. https:// 
doi.org/10.1126/science.aay3164. 
von der Ohe, P., Aalizadeh, R., 2020. S13|EUCOSMETICS|Combined Inventory of 
Ingredients Employed in Cosmetic Products (2000) and Revised Inventory (2006). 
https://doi.org/10.5281/zenodo.3959386. 
Wang, R., Fu, Y., Lai, L., 1997. A new atom-additive method for calculating partition 
coefficients. J. Chem. Inf. Comput. Sci. 37 (3), 615–621. https://doi.org/10.1021/ 
ci960169p. 
Warth, B., Spangler, S., Fang, M., et al., 2017. Exposome-scale investigations guided by 
global metabolomics, pathway analysis, and cognitive computing. Anal. Chem. 
https://doi.org/10.1021/acs.analchem.7b02759. 
Williams, A.J., Grulke, C.M., Edwards, J., et al., 2017. The CompTox chemistry 
dashboard: a community data resource for environmental chemistry. J Cheminform. 
https://doi.org/10.1186/s13321-017-0247-6. 
Wishart, D., Arndt, D., Pon, A., et al., 2015. T3DB: the toxic exposome database. Nucleic 
Acids Res. 43 (D1), D928–D934. https://doi.org/10.1093/nar/gku1004. 
Wishart, D.S., Tzur, D., Knox, C., et al., 2007. HMDB: The human metabolome database. 
Nucleic Acids Res. 35 (SUPPL. 1), 521–526. https://doi.org/10.1093/nar/gkl923. 
Wishart, D.S., Feunang, Y.D., Marcu, A., et al., 2018. HMDB 4.0: the human metabolome 
database for 2018. Nucleic Acids Res. https://doi.org/10.1093/nar/gkx1089. 
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